# Sentinel Lymph Node in Early-Stage Endometrium Cancer

> **NCT06163963** · NA · RECRUITING · sponsor: **Istanbul University** · enrollment: 100 (estimated)

## Conditions studied

- Sentinel Lymph Node
- Endometrial Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Sentinel Lymph Node Mapping With Double Tracer and Double Injection Sites in Early-Stage Endometrium Cancer
- **DIAGNOSTIC_TEST:** charcoal injection to uterus to map sentinel lymph nodes

## Key facts

- **NCT ID:** NCT06163963
- **Lead sponsor:** Istanbul University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-01
- **Primary completion:** 2025-11
- **Final completion:** 2026-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06163963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06163963, "Sentinel Lymph Node in Early-Stage Endometrium Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06163963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*